Diamond Hill Capital Invests in InfuSystem (INFU) Due to Strong Payer Network
In its Q2 2026 investor letter, Diamond Hill Capital Small Cap Strategy highlighted a new position in InfuSystem Holdings, Inc. (NYSE: INFU), citing the company's strong payer network and improving profitability as key factors driving investment interest. InfuSystem provides medical device management services for ambulatory infusion pumps used primarily in cancer treatment. The firm benefits from operational efficiencies, favorable product mix, and a robust balance sheet that supports disciplined capital allocation. Diamond Hill Capital emphasized these strengths while noting the company's position outside of AI-driven sectors which dominated market gains during the quarter. The fund outperformed the Russell 2000 Index in Q2 with strong stock selections in healthcare and industrials offsetting underperformance from its reduced exposure to information technology stocks. InfuSystem closed at $12.18 per share on September 3, 2026.
Tickers: $INFU
Topics: Diamond Hill Capital healthcare services infuSystem Small Cap Strategy